Personal Information
Organization / Workplace
Greater Boston Area United States
Occupation
Assoc. Director, Drug substances
About
- Ph.D. in synthetic organic chemistry, B.S. in chemical engineering.
- 15 years of pharma/biotech industry experience in both drug discovery and development settings.
- A goal-oriented problem-solver with a proven track record of implementing robust, safe, and economical solutions to challenging chemical problems.
Tags
fviii
hemophilia a
bla
novoeight
fda
inhibitor
hiv
integrase
discovery
raltegravir
drug
See more
Presentations
(2)Likes
(24)Hit2Lead by example: checkpoint kinase inhibitors
Vladimir Chupakhin
•
13 years ago
Stability Of Carbon 14 Labelled Compounds
seankitson
•
12 years ago
A Lifecycle Approach to Process Validation
Institute of Validation Technology
•
11 years ago
The development & approval of Novoeight, a case study
Allen Che
•
9 years ago
Part 4: New HIV Treatment Pipeline
NAPWA
•
15 years ago
BioEntrepreneurship: Intellectual Property: What Do Investors Look For?
MaRS Discovery District
•
16 years ago
Towards Personalized Medicine
Michel Dumontier
•
15 years ago
Business Models For Biotech Firms
Alberto Onetti
•
15 years ago
BioEntrepreneurship: The Business of Biotech
MaRS Discovery District
•
16 years ago
Considerations On Biotech And Medtech Fundraising
EstherMM
•
15 years ago
The Drug Development Process Kerentech
EstherMM
•
15 years ago
Optimizing Preclinical Proof of Concept
MaRS Discovery District
•
15 years ago
Canada - China Bio/Pharma Bridge
peterloorits
•
14 years ago
Messages and drug master files in hospital e-prescription
Simon Letellier
•
17 years ago
Drug Master Files for FDA/CDER
bergerb2
•
17 years ago
Toxicology in Drug Development
MaRS Discovery District
•
16 years ago
GMP AND cGMP CONSIDERATIONS
Prof. Dr. Basavaraj Nanjwade
•
15 years ago
How to Draft a Patent
MaRS Discovery District
•
14 years ago
Traditional Chinese Medicine
Fieldgarodie
•
15 years ago
Regulatory Guidelines For Preclinical And Clinical Validation of Traditional Medicines
Prof. Dr. Basavaraj Nanjwade
•
15 years ago
Drug Discovery New Drug Development Process
Prof. Dr. Basavaraj Nanjwade
•
15 years ago
Business Butterflies: The Power Of Social Media
Lara McCulloch-Carter
•
14 years ago
Drug Discovery - The Origin of New Chemical Entity Pharmaceuticals
MaRS Discovery District
•
16 years ago
Introduction To Drug Discovery
ubio Biotechnology Systems Pvt Ltd
•
16 years ago
Personal Information
Organization / Workplace
Greater Boston Area United States
Occupation
Assoc. Director, Drug substances
About
- Ph.D. in synthetic organic chemistry, B.S. in chemical engineering.
- 15 years of pharma/biotech industry experience in both drug discovery and development settings.
- A goal-oriented problem-solver with a proven track record of implementing robust, safe, and economical solutions to challenging chemical problems.
Tags
fviii
hemophilia a
bla
novoeight
fda
inhibitor
hiv
integrase
discovery
raltegravir
drug
See more